Article
Study on amniotic fluid metabolism in the second trimester of Trisomy 21
10 Nov 2019
Abstract excerpt
BACKGROUND: Trisomy 21 is a common aneuploid condition in humans and accounts for approximately one quarter of all aneuploid live births. To date, early diagnosis of Trisomy 21 remains a challenging task. Metabolomics may prove an innovative tool to study the early pathophysiology of Trisomy 21 at a functional level. METHODS: Ultra-performance liquid chromatography coupled with mass spectrometer (UPLC-MS) was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
